NMPA Issued the Guidelines for the Verification of Medical Device Registration Quality Management System
NMPA has organized the formulation of and released on March 17, 2020 the Guidelines for Medical Device Registration Quality Management System Verification.
Announcement of NMPA, GAC, and SAMR on Implementing the Measures for the Administration of Imported Medicinal Materials
National Medical Products Administration, the General Administration of Customs and the State Administration for Market Regulation issued the Announcement on Implementing the Measures for the Administration of Imported Medicinal Materials and related matters to clarify issues pertaining to the application and approval of initial import, record filing and port inspection of imported medicinal materials.
The State Council's Leading Group for Deepening the Reform of the Medical and Health System Issued the Notice on Policies and Measures to Further Deepen the Reform of the Medical and Health System with Centralized Procurement & Use of Drugs as a Breakthrough
The Notice pointed out that it is necessary to promote the interlocked reform of health care, health insurance, and pharmaceuticals, magnify the effects of reform, and better address the problems complicating medical services to the people.
NMPA Issued the Announcement on Issues Pertaining to the Implementation of the Drug Administration Law of the People's Republic of China
NMPA issued the Announcement on Issues Pertaining to the Implementation of the Drug Administration Law of the People's Republic of China (2019 No. 103).
NMPA Issued the Notice on the Implementation Plan of the State Council for Full-Coverage Pilot Reform of Separated Management of Permit and License in the Free Trade Pilot Areas
NMPA issued a corresponding pilot implementation plan covering five parts:the guiding ideology, the scope and content of the pilot, the classified promotion of the reform of the examination and approval system,the improvement of the supporting measures for reform, and the effectiveimplementation of the reform policy.
NMPA and NHC Jointly Issued the Announcement on Regulations for the Administration of Drug Clinical Trial Institutions
NMPA has formulated,in conjunction with the National Health and Health Commission (NHC), the Regulations for the Administration of Drug Clinical Trial Institutions, which has been released on November 29, 2019, and shall take effect as from December 1, 2019.